134 related articles for article (PubMed ID: 17679557)
21. Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy.
Liu Y; Deisseroth A
Cancer Gene Ther; 2006 Sep; 13(9):845-55. PubMed ID: 16710344
[TBL] [Abstract][Full Text] [Related]
22. Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms.
Akbulut H; Tang Y; Maynard J; Zhang L; Pizzorno G; Deisseroth A
Clin Cancer Res; 2004 Nov; 10(22):7738-46. PubMed ID: 15570008
[TBL] [Abstract][Full Text] [Related]
23. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
25. A Bicistronic Adenoviral Vector Carrying Cytosine Deaminase and Granulocyte-Macrophage Colony-Stimulating Factor Increases the Therapeutic Efficacy of Cancer Gene Therapy.
Akbulut H; Coleri A; Sahin G; Tang Y; Icli F
Hum Gene Ther; 2019 Aug; 30(8):999-1007. PubMed ID: 30892086
[TBL] [Abstract][Full Text] [Related]
26. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
28. Human Sulfatase-1 Improves the Effectiveness of Cytosine Deaminase Suicide Gene Therapy with 5-Fluorocytosine Treatment on Hepatocellular Carcinoma Cell Line HepG2 In Vitro and In Vivo.
Yang XP; Liu L; Wang P; Ma SL
Chin Med J (Engl); 2015 May; 128(10):1384-90. PubMed ID: 25963362
[TBL] [Abstract][Full Text] [Related]
29. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
Bilbao R; Gérolami R; Bralet MP; Qian C; Tran PL; Tennant B; Prieto J; Bréchot C
Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
[TBL] [Abstract][Full Text] [Related]
30. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
[TBL] [Abstract][Full Text] [Related]
31. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
[TBL] [Abstract][Full Text] [Related]
32. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H
Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675
[TBL] [Abstract][Full Text] [Related]
33. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
34. Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma.
Zhang L; Akbulut H; Tang Y; Peng X; Pizzorno G; Sapi E; Manegold S; Deisseroth A
Mol Ther; 2002 Sep; 6(3):386-93. PubMed ID: 12231175
[TBL] [Abstract][Full Text] [Related]
35. Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.
Zhang M; Li S; Nyati MK; DeRemer S; Parsels J; Rehemtulla A; Ensminger WD; Lawrence TS
Cancer Res; 2003 Feb; 63(3):658-63. PubMed ID: 12566311
[TBL] [Abstract][Full Text] [Related]
36. Replicating adenoviral vector-mediated transfer of a heat-inducible double suicide gene for gene therapy.
Lee YJ; Galoforo SS; Battle P; Lee H; Corry PM; Jessup JM
Cancer Gene Ther; 2001 Jun; 8(6):397-404. PubMed ID: 11498759
[TBL] [Abstract][Full Text] [Related]
37. Killing effect of coexpressing cytosine deaminase and thymidine kinase on rat vascular smooth muscle cells.
Cao HQ; Meng XM; Liu DQ; Zhao XW; Ding JF
Chin Med J (Engl); 2004 Oct; 117(10):1464-70. PubMed ID: 15498366
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector.
Arbuthnot PB; Bralet MP; Le Jossic C; Dedieu JF; Perricaudet M; Bréchot C; Ferry N
Hum Gene Ther; 1996 Aug; 7(13):1503-14. PubMed ID: 8864751
[TBL] [Abstract][Full Text] [Related]
39. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.
Kaliberov SA; Market JM; Gillespie GY; Krendelchtchikova V; Della Manna D; Sellers JC; Kaliberova LN; Black ME; Buchsbaum DJ
Gene Ther; 2007 Jul; 14(14):1111-9. PubMed ID: 17495948
[TBL] [Abstract][Full Text] [Related]
40. In vivo expression of prostate-specific adenoviral vectors in a canine model.
Steiner MS; Zhang Y; Carraher J; Lu Y
Cancer Gene Ther; 1999; 6(5):456-64. PubMed ID: 10505856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
